These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19221462)

  • 1. ARF, autophagy and tumor suppression.
    Pimkina J; Murphy ME
    Autophagy; 2009 Apr; 5(3):397-9. PubMed ID: 19221462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conserved domain in exon 2 coding for the human and murine ARF tumor suppressor protein is required for autophagy induction.
    Budina-Kolomets A; Hontz RD; Pimkina J; Murphy ME
    Autophagy; 2013 Oct; 9(10):1553-65. PubMed ID: 23939042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targets in the ARF tumor suppressor pathway.
    Saporita AJ; Maggi LB; Apicelli AJ; Weber JD
    Curr Med Chem; 2007; 14(17):1815-27. PubMed ID: 17627519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ARF tumor suppressor can promote the progression of some tumors.
    Humbey O; Pimkina J; Zilfou JT; Jarnik M; Dominguez-Brauer C; Burgess DJ; Eischen CM; Murphy ME
    Cancer Res; 2008 Dec; 68(23):9608-13. PubMed ID: 19047137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of the Conserved Threonine 8 within the Human ARF Tumour Suppressor Protein Regulates Autophagy.
    Fontana R; Guidone D; Angrisano T; Calabrò V; Pollice A; La Mantia G; Vivo M
    Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
    Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
    Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
    Eischen CM; Alt JR; Wang P
    Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-Dependent and p53-independent activation of autophagy by ARF.
    Abida WM; Gu W
    Cancer Res; 2008 Jan; 68(2):352-7. PubMed ID: 18199527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppression by ARF: gatekeeper and caretaker.
    Dominguez-Brauer C; Brauer PM; Chen YJ; Pimkina J; Raychaudhuri P
    Cell Cycle; 2010 Jan; 9(1):86-9. PubMed ID: 20016279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy induction by leptin contributes to suppression of apoptosis in cancer cells and xenograft model: involvement of p53/FoxO3A axis.
    Nepal S; Kim MJ; Hong JT; Kim SH; Sohn DH; Lee SH; Song K; Choi DY; Lee ES; Park PH
    Oncotarget; 2015 Mar; 6(9):7166-81. PubMed ID: 25704884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of leukocyte marker CD43 causes activation of the tumor suppressor proteins p53 and ARF.
    Kadaja L; Laos S; Maimets T
    Oncogene; 2004 Apr; 23(14):2523-30. PubMed ID: 14676827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
    Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
    Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TRIP from ULF to ARF.
    Collado M; Serrano M
    Cancer Cell; 2010 Apr; 17(4):317-8. PubMed ID: 20385357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor spectrum in ARF-deficient mice.
    Kamijo T; Bodner S; van de Kamp E; Randle DH; Sherr CJ
    Cancer Res; 1999 May; 59(9):2217-22. PubMed ID: 10232611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.
    Khoo CM; Carrasco DR; Bosenberg MW; Paik JH; Depinho RA
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3931-6. PubMed ID: 17360455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the ARF-p53 pathway by the small DNA tumor viruses.
    O'Shea CC; Fried M
    Cell Cycle; 2005 Mar; 4(3):449-52. PubMed ID: 15738654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The INK4a/ARF network in tumour suppression.
    Sherr CJ
    Nat Rev Mol Cell Biol; 2001 Oct; 2(10):731-7. PubMed ID: 11584300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment.
    Sui X; Jin L; Huang X; Geng S; He C; Hu X
    Autophagy; 2011 Jun; 7(6):565-71. PubMed ID: 21099252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.
    Gjerset RA
    J Mol Histol; 2006 Sep; 37(5-7):239-51. PubMed ID: 16855788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.